

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.96833087 |
| 2 | proteasome assembly (GO:0043248) | 4.95863448 |
| 3 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 4.24903041 |
| 4 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 4.22882355 |
| 5 | rRNA modification (GO:0000154) | 4.21367955 |
| 6 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.13452015 |
| 7 | DNA double-strand break processing (GO:0000729) | 4.08338804 |
| 8 | respiratory chain complex IV assembly (GO:0008535) | 4.01406067 |
| 9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.90770014 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.90396431 |
| 11 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.85515790 |
| 12 | ATP synthesis coupled proton transport (GO:0015986) | 3.83932942 |
| 13 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.83932942 |
| 14 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.70774076 |
| 15 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.66898029 |
| 16 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.64830097 |
| 17 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.62245805 |
| 18 | purine nucleobase biosynthetic process (GO:0009113) | 3.61044932 |
| 19 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.59361758 |
| 20 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.59361758 |
| 21 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.59361758 |
| 22 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.59262136 |
| 23 | cytochrome complex assembly (GO:0017004) | 3.58802393 |
| 24 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.57301071 |
| 25 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.56716726 |
| 26 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.56716726 |
| 27 | nucleobase biosynthetic process (GO:0046112) | 3.56372746 |
| 28 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.50312031 |
| 29 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.50312031 |
| 30 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.45072089 |
| 31 | negative regulation of ligase activity (GO:0051352) | 3.45072089 |
| 32 | branched-chain amino acid catabolic process (GO:0009083) | 3.43239069 |
| 33 | ribosomal large subunit biogenesis (GO:0042273) | 3.42206578 |
| 34 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.41088174 |
| 35 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.41088174 |
| 36 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.36251309 |
| 37 | rRNA methylation (GO:0031167) | 3.34544081 |
| 38 | adenosine metabolic process (GO:0046085) | 3.33547919 |
| 39 | pseudouridine synthesis (GO:0001522) | 3.33264254 |
| 40 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.33024199 |
| 41 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.32418587 |
| 42 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.29610937 |
| 43 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.29340209 |
| 44 | termination of RNA polymerase III transcription (GO:0006386) | 3.29340209 |
| 45 | protein neddylation (GO:0045116) | 3.25435582 |
| 46 | B cell mediated immunity (GO:0019724) | 3.22056175 |
| 47 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.16507475 |
| 48 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.15533785 |
| 49 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.15533785 |
| 50 | spliceosomal snRNP assembly (GO:0000387) | 3.10739105 |
| 51 | positive regulation of ligase activity (GO:0051351) | 3.06753280 |
| 52 | viral mRNA export from host cell nucleus (GO:0046784) | 3.04682648 |
| 53 | CENP-A containing nucleosome assembly (GO:0034080) | 3.02858120 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.01006786 |
| 55 | platelet dense granule organization (GO:0060155) | 2.95010120 |
| 56 | piRNA metabolic process (GO:0034587) | 2.93395971 |
| 57 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.92584907 |
| 58 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.92584907 |
| 59 | isotype switching (GO:0045190) | 2.92584907 |
| 60 | chaperone-mediated protein transport (GO:0072321) | 2.92478165 |
| 61 | protein complex biogenesis (GO:0070271) | 2.92279527 |
| 62 | amino acid salvage (GO:0043102) | 2.88675500 |
| 63 | L-methionine salvage (GO:0071267) | 2.88675500 |
| 64 | L-methionine biosynthetic process (GO:0071265) | 2.88675500 |
| 65 | DNA replication checkpoint (GO:0000076) | 2.88515515 |
| 66 | ribosome assembly (GO:0042255) | 2.88330639 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.86750237 |
| 68 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.86711580 |
| 69 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.86509877 |
| 70 | DNA damage response, detection of DNA damage (GO:0042769) | 2.86464377 |
| 71 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.86239047 |
| 72 | chromatin remodeling at centromere (GO:0031055) | 2.83649087 |
| 73 | branched-chain amino acid metabolic process (GO:0009081) | 2.82824088 |
| 74 | IMP biosynthetic process (GO:0006188) | 2.81264444 |
| 75 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.80881923 |
| 76 | DNA ligation (GO:0006266) | 2.80515050 |
| 77 | positive regulation of cell cycle arrest (GO:0071158) | 2.77107921 |
| 78 | tRNA metabolic process (GO:0006399) | 2.75258181 |
| 79 | tRNA processing (GO:0008033) | 2.75219887 |
| 80 | intra-S DNA damage checkpoint (GO:0031573) | 2.74561300 |
| 81 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.72646082 |
| 82 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.72646082 |
| 83 | NADH dehydrogenase complex assembly (GO:0010257) | 2.72646082 |
| 84 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.71846231 |
| 85 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.71846231 |
| 86 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288) | 2.71140382 |
| 87 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.68895864 |
| 88 | regulation of helicase activity (GO:0051095) | 2.68666664 |
| 89 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.67899180 |
| 90 | cullin deneddylation (GO:0010388) | 2.67759046 |
| 91 | protein deneddylation (GO:0000338) | 2.67746350 |
| 92 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.67701952 |
| 93 | histone mRNA metabolic process (GO:0008334) | 2.67666538 |
| 94 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.67564612 |
| 95 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.67564612 |
| 96 | regulation of centriole replication (GO:0046599) | 2.67210235 |
| 97 | histone exchange (GO:0043486) | 2.66889795 |
| 98 | postreplication repair (GO:0006301) | 2.65949906 |
| 99 | negative regulation of protein ubiquitination (GO:0031397) | 2.64783444 |
| 100 | deoxyribose phosphate catabolic process (GO:0046386) | 2.64263883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.16452277 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.24608233 |
| 3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.84941122 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.91159918 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.85242750 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.84873943 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.80924384 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.76737237 |
| 9 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.70103004 |
| 10 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.69832526 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.68970713 |
| 12 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.59083551 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.58104713 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.52744252 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.51389226 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.51208276 |
| 17 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.43851182 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.38385054 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.34197412 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.32536674 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.27079309 |
| 22 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.24470060 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.17115135 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.08531247 |
| 25 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.01071969 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00109078 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.99185155 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.96664834 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.96489501 |
| 30 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.96454524 |
| 31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.92986484 |
| 32 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.92128660 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91784588 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.71116808 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69958787 |
| 36 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.68733664 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65659393 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.62367432 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.60901544 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.60253870 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57893490 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56710241 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.56257038 |
| 44 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52586272 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46813219 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43471872 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41688235 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39337057 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.35277549 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35172640 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.32927805 |
| 52 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31718149 |
| 53 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.31258435 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.29437393 |
| 55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.27944904 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26517043 |
| 57 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.25168347 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23169878 |
| 59 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21783141 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18881095 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18166788 |
| 62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14852431 |
| 63 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14852431 |
| 64 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14043356 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13858969 |
| 66 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.13208650 |
| 67 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.11646063 |
| 68 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09568845 |
| 69 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.08241916 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.07312431 |
| 71 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07267480 |
| 72 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05997694 |
| 73 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05997694 |
| 74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05165347 |
| 75 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04488141 |
| 76 | AR_20517297_ChIP-Seq_VCAP_Human | 1.04372309 |
| 77 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00437082 |
| 78 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.00025547 |
| 79 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.99632739 |
| 80 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99202210 |
| 81 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98833228 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97963124 |
| 83 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97265691 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96406656 |
| 85 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95613695 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94970870 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94428420 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94288615 |
| 89 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92755023 |
| 90 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92301525 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91211522 |
| 92 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90592718 |
| 93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.90538519 |
| 94 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.88821770 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88299503 |
| 96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87696331 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.86145060 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86083806 |
| 99 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.85315391 |
| 100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83980525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.39216943 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.36958162 |
| 3 | MP0009697_abnormal_copulation | 2.99517292 |
| 4 | MP0004147_increased_porphyrin_level | 2.94766231 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 2.83720439 |
| 6 | MP0005671_abnormal_response_to | 2.82192367 |
| 7 | MP0008058_abnormal_DNA_repair | 2.53560229 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.53157304 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.41522943 |
| 10 | MP0006054_spinal_hemorrhage | 2.36649648 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.29066602 |
| 12 | MP0008872_abnormal_physiological_respon | 2.28641735 |
| 13 | MP0005646_abnormal_pituitary_gland | 2.21933015 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 1.99090542 |
| 15 | MP0008877_abnormal_DNA_methylation | 1.86939050 |
| 16 | MP0009785_altered_susceptibility_to | 1.85320713 |
| 17 | MP0001800_abnormal_humoral_immune | 1.85073395 |
| 18 | MP0000685_abnormal_immune_system | 1.83602046 |
| 19 | MP0002736_abnormal_nociception_after | 1.80322848 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.77620464 |
| 21 | MP0003786_premature_aging | 1.76777854 |
| 22 | MP0003718_maternal_effect | 1.74036863 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 1.72720301 |
| 24 | MP0003186_abnormal_redox_activity | 1.71191506 |
| 25 | MP0005645_abnormal_hypothalamus_physiol | 1.70848100 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.68317583 |
| 27 | MP0002254_reproductive_system_inflammat | 1.67431948 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.64088564 |
| 29 | MP0003646_muscle_fatigue | 1.61965860 |
| 30 | MP0003303_peritoneal_inflammation | 1.61535641 |
| 31 | MP0003693_abnormal_embryo_hatching | 1.60007847 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.59964855 |
| 33 | MP0001764_abnormal_homeostasis | 1.59870501 |
| 34 | MP0001529_abnormal_vocalization | 1.56966505 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.50795930 |
| 36 | MP0006035_abnormal_mitochondrial_morpho | 1.47358548 |
| 37 | MP0002102_abnormal_ear_morphology | 1.45463029 |
| 38 | MP0002006_tumorigenesis | 1.43850991 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.41187172 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.39867428 |
| 41 | MP0005379_endocrine/exocrine_gland_phen | 1.39616334 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.38901413 |
| 43 | MP0002723_abnormal_immune_serum | 1.38379430 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.34738104 |
| 45 | MP0001819_abnormal_immune_cell | 1.33817113 |
| 46 | MP0009764_decreased_sensitivity_to | 1.32545598 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.30766074 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.27779585 |
| 49 | MP0002163_abnormal_gland_morphology | 1.27120866 |
| 50 | MP0001790_abnormal_immune_system | 1.26008859 |
| 51 | MP0005387_immune_system_phenotype | 1.26008859 |
| 52 | MP0003111_abnormal_nucleus_morphology | 1.23222673 |
| 53 | MP0006072_abnormal_retinal_apoptosis | 1.20923606 |
| 54 | MP0002398_abnormal_bone_marrow | 1.19809798 |
| 55 | MP0008007_abnormal_cellular_replicative | 1.17524609 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.16086931 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.14554162 |
| 58 | MP0000689_abnormal_spleen_morphology | 1.12893997 |
| 59 | MP0005025_abnormal_response_to | 1.11184247 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.09109967 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.08093459 |
| 62 | MP0003077_abnormal_cell_cycle | 1.05095064 |
| 63 | MP0003787_abnormal_imprinting | 1.03756314 |
| 64 | MP0003890_abnormal_embryonic-extraembry | 1.03499569 |
| 65 | MP0003866_abnormal_defecation | 1.00887962 |
| 66 | MP0009278_abnormal_bone_marrow | 0.99086488 |
| 67 | MP0003195_calcinosis | 0.98609548 |
| 68 | MP0002405_respiratory_system_inflammati | 0.97276799 |
| 69 | MP0001845_abnormal_inflammatory_respons | 0.95816679 |
| 70 | MP0003075_altered_response_to | 0.95443624 |
| 71 | MP0001545_abnormal_hematopoietic_system | 0.94956689 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 0.94956689 |
| 73 | MP0008873_increased_physiological_sensi | 0.94368676 |
| 74 | MP0000716_abnormal_immune_system | 0.93741813 |
| 75 | MP0008875_abnormal_xenobiotic_pharmacok | 0.93068329 |
| 76 | MP0000358_abnormal_cell_content/ | 0.92049600 |
| 77 | MP0002429_abnormal_blood_cell | 0.91823419 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.90685383 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.85432444 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.85211066 |
| 81 | MP0000490_abnormal_crypts_of | 0.84565567 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.82835734 |
| 83 | MP0001293_anophthalmia | 0.82388643 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.81987178 |
| 85 | MP0002419_abnormal_innate_immunity | 0.81214797 |
| 86 | MP0002722_abnormal_immune_system | 0.79713183 |
| 87 | MP0001873_stomach_inflammation | 0.79428953 |
| 88 | MP0008004_abnormal_stomach_pH | 0.78773229 |
| 89 | MP0005389_reproductive_system_phenotype | 0.78456806 |
| 90 | MP0008469_abnormal_protein_level | 0.78181933 |
| 91 | MP0005332_abnormal_amino_acid | 0.76986605 |
| 92 | MP0001879_abnormal_lymphatic_vessel | 0.76567582 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.76497809 |
| 94 | MP0005165_increased_susceptibility_to | 0.76339419 |
| 95 | MP0002396_abnormal_hematopoietic_system | 0.75020288 |
| 96 | MP0001929_abnormal_gametogenesis | 0.71986547 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 0.71838051 |
| 98 | MP0004084_abnormal_cardiac_muscle | 0.71655200 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.70629614 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.68677017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 2 muscle fiber atrophy (HP:0003554) | 4.31279235 |
| 2 | Methylmalonic acidemia (HP:0002912) | 3.59087744 |
| 3 | Muscle fiber atrophy (HP:0100295) | 3.57156633 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 3.56267971 |
| 5 | Increased CSF lactate (HP:0002490) | 3.56205958 |
| 6 | Hepatocellular necrosis (HP:0001404) | 3.51291125 |
| 7 | Type I transferrin isoform profile (HP:0003642) | 3.47848059 |
| 8 | Hepatic necrosis (HP:0002605) | 3.33919584 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.31973410 |
| 10 | Acute encephalopathy (HP:0006846) | 3.30961397 |
| 11 | 3-Methylglutaconic aciduria (HP:0003535) | 3.23424944 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.20754886 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.14997532 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.11803152 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.11491665 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.11491665 |
| 17 | Methylmalonic aciduria (HP:0012120) | 3.05647001 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.02827896 |
| 19 | Lipid accumulation in hepatocytes (HP:0006561) | 3.01026272 |
| 20 | Reduced antithrombin III activity (HP:0001976) | 2.99864241 |
| 21 | Cerebral edema (HP:0002181) | 2.96838475 |
| 22 | IgG deficiency (HP:0004315) | 2.95130147 |
| 23 | Stomatitis (HP:0010280) | 2.92894097 |
| 24 | Increased serum lactate (HP:0002151) | 2.91710228 |
| 25 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.86933797 |
| 26 | Abnormality of alanine metabolism (HP:0010916) | 2.86933797 |
| 27 | Hyperalaninemia (HP:0003348) | 2.86933797 |
| 28 | Hyperglycinemia (HP:0002154) | 2.79054858 |
| 29 | Facial diplegia (HP:0001349) | 2.67103037 |
| 30 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.65500491 |
| 31 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.65500491 |
| 32 | Abnormal protein glycosylation (HP:0012346) | 2.65500491 |
| 33 | Abnormal glycosylation (HP:0012345) | 2.65500491 |
| 34 | Degeneration of anterior horn cells (HP:0002398) | 2.65355364 |
| 35 | Abnormality of the anterior horn cell (HP:0006802) | 2.65355364 |
| 36 | Hypoproteinemia (HP:0003075) | 2.63691935 |
| 37 | Lethargy (HP:0001254) | 2.56893188 |
| 38 | IgM deficiency (HP:0002850) | 2.55611883 |
| 39 | Lactic acidosis (HP:0003128) | 2.53765125 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.52612307 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.51598825 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.48721070 |
| 43 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.48416855 |
| 44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.47659798 |
| 45 | Exertional dyspnea (HP:0002875) | 2.47336230 |
| 46 | Colon cancer (HP:0003003) | 2.43481772 |
| 47 | Abnormality of vitamin B metabolism (HP:0004340) | 2.39855468 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.36929453 |
| 49 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.32724053 |
| 50 | Abnormality of glycine metabolism (HP:0010895) | 2.32724053 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.32723732 |
| 52 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.29087808 |
| 53 | Hyperglycinuria (HP:0003108) | 2.28178914 |
| 54 | Respiratory failure (HP:0002878) | 2.24014836 |
| 55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19146158 |
| 56 | Volvulus (HP:0002580) | 2.17914978 |
| 57 | Severe combined immunodeficiency (HP:0004430) | 2.12057770 |
| 58 | Increased intramyocellular lipid droplets (HP:0012240) | 2.10200800 |
| 59 | Ketosis (HP:0001946) | 2.09823202 |
| 60 | Renal Fanconi syndrome (HP:0001994) | 2.09760445 |
| 61 | Ketoacidosis (HP:0001993) | 2.09619957 |
| 62 | Spinal muscular atrophy (HP:0007269) | 2.08503784 |
| 63 | CNS demyelination (HP:0007305) | 2.07925382 |
| 64 | B lymphocytopenia (HP:0010976) | 2.04528254 |
| 65 | Pancreatic cysts (HP:0001737) | 2.01188932 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.00786120 |
| 67 | Abnormality of the prostate (HP:0008775) | 1.99393300 |
| 68 | Respiratory difficulties (HP:0002880) | 1.98118679 |
| 69 | Tongue fasciculations (HP:0001308) | 1.97782168 |
| 70 | Cerebral hypomyelination (HP:0006808) | 1.96038401 |
| 71 | Abnormality of the ileum (HP:0001549) | 1.92288754 |
| 72 | Intestinal atresia (HP:0011100) | 1.89203837 |
| 73 | Abolished electroretinogram (ERG) (HP:0000550) | 1.88257715 |
| 74 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.86294442 |
| 75 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.86294442 |
| 76 | Meningioma (HP:0002858) | 1.86278702 |
| 77 | Hypothermia (HP:0002045) | 1.84216439 |
| 78 | Clubbing of toes (HP:0100760) | 1.83482274 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.83322654 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 1.83322654 |
| 81 | Increased IgM level (HP:0003496) | 1.82370344 |
| 82 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.81820579 |
| 83 | Aplastic anemia (HP:0001915) | 1.79942002 |
| 84 | Albinism (HP:0001022) | 1.79813181 |
| 85 | Attenuation of retinal blood vessels (HP:0007843) | 1.79765323 |
| 86 | Abnormal spermatogenesis (HP:0008669) | 1.78195701 |
| 87 | Optic disc pallor (HP:0000543) | 1.77521759 |
| 88 | Prostate neoplasm (HP:0100787) | 1.77434890 |
| 89 | Stomach cancer (HP:0012126) | 1.76552282 |
| 90 | Palpitations (HP:0001962) | 1.76036870 |
| 91 | CNS hypomyelination (HP:0003429) | 1.74738649 |
| 92 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.74618985 |
| 93 | Microvesicular hepatic steatosis (HP:0001414) | 1.74495842 |
| 94 | Meckel diverticulum (HP:0002245) | 1.74399636 |
| 95 | Renal cortical cysts (HP:0000803) | 1.73439231 |
| 96 | Cerebral hemorrhage (HP:0001342) | 1.72849585 |
| 97 | Constricted visual fields (HP:0001133) | 1.72696457 |
| 98 | Pancytopenia (HP:0001876) | 1.72225383 |
| 99 | Combined immunodeficiency (HP:0005387) | 1.71724082 |
| 100 | Increased muscle lipid content (HP:0009058) | 1.71065527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.89978182 |
| 2 | ZAK | 3.40682667 |
| 3 | EIF2AK3 | 3.32419543 |
| 4 | PLK4 | 3.14007825 |
| 5 | NUAK1 | 2.98194544 |
| 6 | TAOK3 | 2.95695473 |
| 7 | NEK1 | 2.77392002 |
| 8 | VRK2 | 2.68799947 |
| 9 | MKNK1 | 2.55727967 |
| 10 | TLK1 | 2.32862007 |
| 11 | MST4 | 2.12764420 |
| 12 | MAP4K2 | 2.07694665 |
| 13 | BCKDK | 2.07250452 |
| 14 | TSSK6 | 2.06781059 |
| 15 | BMPR1B | 1.99476620 |
| 16 | VRK1 | 1.96814489 |
| 17 | TEC | 1.84967901 |
| 18 | PLK3 | 1.82250883 |
| 19 | MAP3K12 | 1.80845418 |
| 20 | GRK1 | 1.74248315 |
| 21 | TAF1 | 1.67900718 |
| 22 | ADRBK2 | 1.67398215 |
| 23 | WNK3 | 1.66249569 |
| 24 | EIF2AK1 | 1.54545786 |
| 25 | MKNK2 | 1.49288068 |
| 26 | TRIM28 | 1.48592713 |
| 27 | SRPK1 | 1.42691644 |
| 28 | BUB1 | 1.38254636 |
| 29 | KIT | 1.37168828 |
| 30 | BRSK2 | 1.26212508 |
| 31 | SCYL2 | 1.16612630 |
| 32 | WEE1 | 1.16139163 |
| 33 | EIF2AK2 | 1.15830879 |
| 34 | TTK | 1.15359617 |
| 35 | PBK | 1.15342220 |
| 36 | MYLK | 1.15017495 |
| 37 | ACVR1B | 1.14773285 |
| 38 | MAPKAPK5 | 1.14419360 |
| 39 | FES | 1.11745824 |
| 40 | NME2 | 1.11161339 |
| 41 | ERBB3 | 0.97530607 |
| 42 | TXK | 0.95671603 |
| 43 | TGFBR1 | 0.92463611 |
| 44 | STK16 | 0.92039770 |
| 45 | CSNK1G3 | 0.89379031 |
| 46 | PINK1 | 0.89332899 |
| 47 | CDC7 | 0.89179844 |
| 48 | IKBKB | 0.88674257 |
| 49 | BMPR2 | 0.87350868 |
| 50 | MAP4K1 | 0.86680770 |
| 51 | PDK2 | 0.86032422 |
| 52 | TNIK | 0.85893435 |
| 53 | DAPK1 | 0.83438703 |
| 54 | OXSR1 | 0.82499444 |
| 55 | KDR | 0.82396896 |
| 56 | CSNK1G1 | 0.78711986 |
| 57 | FRK | 0.77265973 |
| 58 | MAP3K14 | 0.72844544 |
| 59 | IKBKE | 0.70973744 |
| 60 | PLK1 | 0.70680776 |
| 61 | DYRK3 | 0.67212109 |
| 62 | CSNK1G2 | 0.66828234 |
| 63 | PRKCQ | 0.61197261 |
| 64 | CSNK1A1L | 0.61193394 |
| 65 | PASK | 0.59675519 |
| 66 | TNK2 | 0.59629000 |
| 67 | BRAF | 0.59295522 |
| 68 | CCNB1 | 0.58492107 |
| 69 | PIK3CG | 0.58160900 |
| 70 | SYK | 0.56012956 |
| 71 | RIPK4 | 0.55640835 |
| 72 | MATK | 0.52945714 |
| 73 | RPS6KA5 | 0.52910737 |
| 74 | TBK1 | 0.52680187 |
| 75 | ITK | 0.51507956 |
| 76 | PLK2 | 0.49420002 |
| 77 | AURKB | 0.47121074 |
| 78 | ALK | 0.46142196 |
| 79 | DAPK3 | 0.45832220 |
| 80 | JAK3 | 0.45242892 |
| 81 | LYN | 0.44627980 |
| 82 | GRK6 | 0.44113229 |
| 83 | ATR | 0.43310760 |
| 84 | AKT3 | 0.43028040 |
| 85 | PAK4 | 0.41040291 |
| 86 | CHEK2 | 0.39003749 |
| 87 | STK10 | 0.33659326 |
| 88 | CSNK2A1 | 0.33439594 |
| 89 | TESK2 | 0.32659855 |
| 90 | INSRR | 0.31108113 |
| 91 | STK39 | 0.30368607 |
| 92 | ADRBK1 | 0.24820842 |
| 93 | CSNK2A2 | 0.24792235 |
| 94 | IGF1R | 0.24316086 |
| 95 | RPS6KB2 | 0.24232474 |
| 96 | MAP3K8 | 0.23756763 |
| 97 | ILK | 0.22226967 |
| 98 | MAP3K13 | 0.21835139 |
| 99 | CHUK | 0.21025464 |
| 100 | ATM | 0.20855089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.55823091 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.99827071 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.72097163 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.62833630 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.50900680 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.49504476 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.36509328 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.34727515 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.34333176 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.30947170 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.25852946 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.22750985 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.15689584 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.14502946 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.02289075 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 2.00761117 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.95425600 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94387090 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 1.91154746 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.89482558 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.81970546 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.78533657 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.76138686 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74398763 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.69836191 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61560829 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.57807645 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57235831 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48391874 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.48299240 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46828795 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.37836292 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36953772 |
| 34 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.33702021 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25043645 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20156812 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.19927960 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13102540 |
| 39 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.12511342 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12451675 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09166830 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08893393 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07930512 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03939622 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03688384 |
| 46 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01214832 |
| 47 | Purine metabolism_Homo sapiens_hsa00230 | 1.00703750 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 0.95625760 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95081559 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94153851 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93990476 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93944065 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.92703292 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92684342 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91287523 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86872973 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80985468 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79629533 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79618432 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.78296488 |
| 61 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77039628 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74455971 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72754536 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71698131 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.66673372 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 0.62591027 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61036365 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60090262 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53903670 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52618407 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51029522 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50168546 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46470212 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46342291 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45120810 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44727943 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44608241 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.43819793 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43658282 |
| 80 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.43631243 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39809355 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39441182 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.38054781 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37711937 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.36916211 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36054373 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35742338 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33607559 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32809777 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31783022 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31160512 |
| 92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.29590634 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28498809 |
| 94 | Measles_Homo sapiens_hsa05162 | 0.26825403 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26728580 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.26615783 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.26595537 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23915293 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.22331508 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.22294089 |

